Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines.
ABCB1
ABCC1
YM155
drug resistance
neuroblastoma
survivin
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
02 Mar 2020
02 Mar 2020
Historique:
received:
27
01
2020
revised:
27
02
2020
accepted:
28
02
2020
entrez:
6
3
2020
pubmed:
7
3
2020
medline:
7
3
2020
Statut:
epublish
Résumé
The survivin suppressant YM155 is a drug candidate for neuroblastoma. Here, we tested YM155 in 101 neuroblastoma cell lines (19 parental cell lines, 82 drug-adapted sublines). Seventy seven (77) cell lines displayed YM155 IC
Identifiants
pubmed: 32131402
pii: cancers12030577
doi: 10.3390/cancers12030577
pmc: PMC7139505
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Hilfe für krebskranke Kinder Frankfurt e.V.
ID : n/a
Organisme : Frankfurter Stiftung für krebskranke Kinder
ID : n/a
Références
Chem Biol. 2010 May 28;17(5):421-33
pubmed: 20534341
Cancer Cell. 2012 Sep 11;22(3):373-88
pubmed: 22975379
Cancer Lett. 2015 Sep 28;366(1):44-51
pubmed: 26118775
J Pharmacol Exp Ther. 1999 Aug;290(2):854-62
pubmed: 10411602
Nat Chem Biol. 2014 Sep;10(9):768-773
pubmed: 25064833
Nat Rev Cancer. 2007 Aug;7(8):573-84
pubmed: 17625587
Oncotarget. 2014 Nov 15;5(21):10237-50
pubmed: 25296978
Oncogene. 2016 Apr 21;35(16):2052-61
pubmed: 26148234
Cancer Res. 2007 Sep 1;67(17):8014-21
pubmed: 17804712
J Pediatr Hematol Oncol. 2013 Jul;35(5):337-47
pubmed: 23703550
Br J Cancer. 1995 Aug;72(2):418-23
pubmed: 7640227
Oncotarget. 2016 Mar 8;7(10):11664-76
pubmed: 26887049
Cancer. 1997 Oct 1;80(7):1250-7
pubmed: 9317175
J Pediatr Surg. 2009 Feb;44(2):377-80
pubmed: 19231538
Cell Death Dis. 2016 Oct 13;7(10):e2410
pubmed: 27735941
Eur J Cancer. 2012 Mar;48(5):763-71
pubmed: 22088485
Oncotarget. 2015 Jul 10;6(19):17605-20
pubmed: 25749379
Pol J Pathol. 2009;60(4):168-73
pubmed: 20072950
Nature. 2010 Dec 16;468(7326):973-7
pubmed: 21107323
Cancer Chemother Pharmacol. 2012 Jul;70(1):207-12
pubmed: 22526412
Ann Oncol. 2012 Apr;23(4):968-73
pubmed: 21859898
Int J Cancer. 2003 Mar 10;104(1):36-43
pubmed: 12532417
Cancer Chemother Pharmacol. 2016 Jun;77(6):1103-24
pubmed: 26886018
Oncogene. 1996 Aug 15;13(4):803-12
pubmed: 8761302
Oncotarget. 2016 Sep 6;7(36):58051-58064
pubmed: 27517323
Int J Oncol. 2005 Oct;27(4):1029-37
pubmed: 16142320
Nature. 2011 Nov 23;480(7377):387-90
pubmed: 22113612
Nat Med. 2017 Feb;23(2):250-255
pubmed: 27991919
Biochim Biophys Acta. 2014 Apr;1845(2):202-20
pubmed: 24440709
Pharmacol Ther. 2007 Feb;113(2):429-41
pubmed: 17208306
Curr Med Chem. 2012;19(13):1946-2025
pubmed: 22257057
Transl Oncol. 2013 Dec 01;6(6):685-96
pubmed: 24466371
Curr Med Chem. 2004 Sep;11(18):2443-66
pubmed: 15379707
J Clin Oncol. 2008 Nov 10;26(32):5198-203
pubmed: 18824702
Mol Biotechnol. 2010 Feb;44(2):152-67
pubmed: 19950006
Adv Cancer Res. 2015;125:139-70
pubmed: 25640269
Cell Death Dis. 2011 Dec 15;2:e243
pubmed: 22170099
J Clin Oncol. 2009 Sep 20;27(27):4481-6
pubmed: 19687333
Drug Resist Updat. 2009 Aug-Oct;12(4-5):114-26
pubmed: 19648052
Cancer Discov. 2013 Sep;3(9):1020-9
pubmed: 23779130
Science. 2014 Dec 19;346(6216):1480-6
pubmed: 25394791
Invest New Drugs. 2013 Apr;31(2):443-51
pubmed: 22892872
Drug Metab Dispos. 2011 Dec;39(12):2314-20
pubmed: 21918035
Drug Metab Pharmacokinet. 2012;27(1):85-105
pubmed: 22123128
Biochem Pharmacol. 2011 Nov 1;82(9):1066-72
pubmed: 21784061
Endocr Relat Cancer. 2011 Oct 27;18(6):657-68
pubmed: 21859926
Cancer Sci. 2011 Mar;102(3):614-21
pubmed: 21205082
Curr Med Chem. 2012;19(22):3679-88
pubmed: 22680927
Cancer Lett. 2005 Oct 18;228(1-2):133-41
pubmed: 15927359
Cancer Discov. 2013 Sep;3(9):1030-43
pubmed: 23842682
Cell Death Dis. 2012 Apr 05;3:e294
pubmed: 22476102
J Exp Clin Cancer Res. 2019 Aug 22;38(1):368
pubmed: 31439015
J Cell Sci. 2019 Apr 4;132(7):
pubmed: 30948431
Nat Commun. 2015 Mar 11;6:6377
pubmed: 25758528
Science. 2007 May 18;316(5827):1039-43
pubmed: 17463250
Eur Rev Med Pharmacol Sci. 2013 Nov;17(21):2909-15
pubmed: 24254560
Pediatr Blood Cancer. 2013 Jun;60(6):985-93
pubmed: 23255319
Nat Commun. 2016 Aug 31;7:12609
pubmed: 27576846
Clin Cancer Res. 2009 Jun 1;15(11):3872-80
pubmed: 19470738
J Hematol Oncol. 2015 Apr 22;8:39
pubmed: 25895498